YF343, A Novel Histone Deacetylase Inhibitor, Combined with CQto Inhibit- Autophagy, Contributes to Increased Apoptosis in Triple-Negative Breast Cancer

Post time 7 day(s) ago

journal：Current Medicinal Chemistry

Authors：Na Liu; Tingting Luo; Jing Zhang; Li-na Han; Wen-qi Duan; Wen-xia Lu; Huiran Qiu; Yan Lin; Yong-mei Wu; Hua Zhang; Fei-fei Yang; Di Ge

Published date：2023-12-

DOI：10.2174/0929867330666230120152815

PDF link：https://www.eurekaselect.com/art ... 7330666230120152815

Article link：http://dx.doi.org/10.2174/0929867330666230120152815

Article Source：Bentham Science Publishers Ltd.。

Remark：

Post time 7 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Bentham] YF343, A Novel Histone Deacetylase Inhibitor, Combined with CQto Inhibit- Autophagy, Contributes to Increased Apoptosis in Triple-Negative Breast Cancer

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Bentham] YF343, A Novel Histone Deacetylase Inhibitor, Combined with CQto Inhibit- Autophagy, Contributes to Increased Apoptosis in Triple-Negative Breast Cancer Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Bentham] YF343, A Novel Histone Deacetylase Inhibitor, Combined with CQto Inhibit- Autophagy, Contributes to Increased Apoptosis in Triple-Negative Breast Cancer